R wave in aVL lead (RaVL) is an old ECG index of left ventricular hypertrophy (LVH) described in 1949 by Sokolow and Lyon. 1 During the last decades Sokolow-Lyon index and Cornell voltage or product have been extensively used to detect LVH. 2-5 These 2 latter indexes turned out to have a better diagnostic value but had also some drawbacks such as a specific gender correction, which has probably limited their application in daily practice, particularly for general practitioners.
Original article R wave in aVL lead (RaVL) is an old ECG index of left ventricular hypertrophy (LVH) described in 1949 by Sokolow and Lyon. 1 During the last decades Sokolow-Lyon index and Cornell voltage or product have been extensively used to detect LVH. [2] [3] [4] [5] These 2 latter indexes turned out to have a better diagnostic value but had also some drawbacks such as a specific gender correction, which has probably limited their application in daily practice, particularly for general practitioners.
More recent studies showed for hypertensive patients that RaVL was more tightly correlated with left ventricular mass index (LVMI) than Sokolow-Lyon or Cornell indexes, using transthoracic echocardiography (TTE) as a gold standard. 4, 6 This simple index was also associated with major cardiovascular events, cardiovascular and all-cause mortality in patients with or without LVH assessed by other ECG indexes. 4, 5, 7 The current European Guidelines quoted RaVL as a valid index of LVH and suggested a threshold of 1.1 mV which has a specifity of 100% as described in the old radiographic study of Sokolow. 1, 8 Other optimal cut-off values of RaVL around 0.6 or 0.7 mV have been validated using TTE most of the time [4] [5] [6] and cardiac MRI (CMR) in a small cohort. 9 In these former studies, most of hypertensive patients were Caucasians, free from overt cardiac disease and without conduction disorders raising the question of the significance of RaVL in these settings excluded from previous evaluations.
Thus, the aims of the present study were (i) to compare the diagnostic performance of RaVL with other ECG indexes in particular conditions and (ii) to understand how the relative contributions of each ECG lead to determine LVH or LV enlargement may influence this performance.
MATERIALS AND METHODS

Participants
From April 2007 to March 2014, the study included 501 consecutive subjects referred to 2 cardiology departments (Croix-Rousse Hospital, Lyon, France and Nord Ouest Hospital, Villefranche-sur-Saone, France) for the evaluation and management of various cardiac diseases (aetiologies, LVEF or LVMI assessment, stress imaging testing). Patients were eligible if they had an assessment of LVM by MRI and a 12 lead-ECG within a 4 week-period. Median time between MRI and ECG was 5 days (35% patients had 2 exams within 2 days and 75% within a 2 week-period). All ECGs were retrospectively analyzed by 2 trained cardiologists (P.Y.C. and B.H.) who were blinded to the results of CMR. The reproducibility of ECG LVH indices was assessed in a sample of 30 randomly selected patients from the entire cohort. ECGs were read separately by the same cardiologists (P.Y.C. and B.H.) to test the interobserver and intraobserver reproducibility. We noted a good reproducibility for interobserver and intraobserver measurement of LVH criteria (intra class coefficient of correlation and variability coefficients, Supplementary Table S1 ).
Protocol
A standard 12-lead ECG was recorded at 25 mm/s and 1 mV/cm. The body surface area was calculated using Dubois and Dubois formula; i.e., BSA = 0.20247 × (height) 0.725 × (weight) 0.425 .
The electrical LVH criteria were the followings: RaVL, Sokolow-Lyon index (amplitude of leads SV1 + RV5 or RV6), Cornell voltage criterion (RaVL + SV3), and Cornell product (Cornell voltage criterion × QRS duration). [1] [2] [3] [4] [5] For the 2 last indexes, 3 different gender corrections were suggested: no gender correction, +6 mm added in women and +8 mm added in women. Our CMR protocol has been previously described. 9 CMR was performed with a 1.5 T magnet (Magnetom Symphony Maestro Class, Siemens, Erlangen, Germany). ECG-gated breath-hold segmented cine true fast imaging (True-FISP) was performed in long-axis views (4-and 2-chamber views) and finally in short-axis views. On each short-axis slice, the endocardial and epicardial contours were manually traced at end-diastole. LVM was derived from Simpson's method: after summation of discs, LVM was calculated by subtracting the endocardial volume from the epicardial volume at end-diastole and multiplying the result by 1.05 g/cm 3 . A previously described LVH cut-off value was considered of LVM indexed to the BSA (LVMI): 83 g/m 2 in men and 67 g/m 2 in women. 10 Patients were defined having a LV enlargement using a threshold >92 ml/m 2 . 11,12
Statistical analyses
Quantitative variables were summarized as means ± standard deviations, except those with skewed distributions; these were expressed as medians (boundaries of the interquartile ranges). Categorical variables were expressed as percentages. Student paired or unpaired t-tests and nonparametric ANOVA (Mann-Whitney test) were used to compare continuous variables between groups. χ 2 testing was used to compare dichotomous variables.
The correlations between ECG LVH indexes (RaVL, Sokolow-Lyon index, Cornell voltage criterion, and Cornell product) and LVMI were assessed with a linear regression analysis (Pearson's coefficient of correlation "r"). Coefficients of correlation were compared using Z statistic after Fisher transformation. To estimate the global accuracy of ECG LVH indexes in diagnosing CMR LVH, an empirical receiver-operating characteristic (ROC) curve was built. The area under the ROC curve (AUC) was estimated using the Mann-Whitney statistic and was compared to 50%. Various AUCs were compared using Delong test.
Multiple regression analyses (logistic and forward stepwise) were performed to identify the respective role of each ECG leads (SV1, SV3, RV5, RV6, RaVL, and QRS duration) to determine either LVH or LV enlargement which both may be components of the LV remodeling process and thus of ECG changes. Variables included in the multivariable analysis where those associated with LVMI in univariate analysis with a P value <0.10 and with no major collinearity (R < 0.700). The analyses used SPSS software, release 20.0.0 (SPSS, Chicago, IL) and STATA 12 (Stata Corporation, College Station, TX). A P value <0.05 was considered for statistical significance.
RESULTS
Baseline characteristics of the cohort
The baseline characteristics of our cohort and of some subgroups are summarized in Table 1 . Nearly two-third of patients were men. Around 40% (N = 201) had a previous MI among them, 27 patients had CMR just after the acute phase of MI because coronary angiogram did not notice any significant atherosclerotic stenosis. For the remaining 174 patients, CMR was used several weeks later for a stress-imaging test. Half of the patients were treated for hypertension. One hundred and forty-three patients (28.5%) had LVH according to MRI, 171 subjects (34.1%) had a LV enlargement, and 93 had both conditions. Among patients with LVH, we noted 94 hypertensive cardiomyopathy, 29 ischemic cardiomyopathy, 8 hypertrophic cardiomyopathy, 9 idiopathic dilated cardiomyopathy, 2 cardiac amyloidosis, and 1 aortic stenosis. Patients with previous MI were older, more frequently men and smoker than those without MI. Patients with MI had higher LVMI and LVEDVI on CMR than those without MI.
Correlation of ECG indexes with LVMI
Linear regression analyses are summarized in Supplementary Table S2. In the whole cohort Sokolow-Lyon index, RaVL, Cornell voltage without gender correction and Cornell product were all statistically correlated with LVMI. The best correlations of RaVL with LVMI were observed in patients without MI (R = 0.392, P < 0.001), in Caucasians (R = 0.378, P < 0.001), in women (R = 0.389, P < 0.001), in obese (R = 0.406, P < 0.001) and in patients with right bundle branch block (R = 0.437, P < 0.001). However, the differences of coefficient of correlation were not statistically different in comparison respectively with patients with MI (Z statistic 1. Unless otherwise stated, the data are means ± SD or medians (interquartile ranges). P for comparison between patients without MI and those with MI.
Abbreviations: ACE, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; BMI, body-mass index; bpm, beats per minute; CAD, coronary artery disease; DBP, diastolic blood pressure; HF, heart failure; LVEDVI, left ventricular end-diastolic volume indexed to the body surface area; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass indexed to the body surface area; MI, myocardial infarction; MR, mineralocorticoid receptor antagonists; PAD, peripheral artery disease; RaVL, amplitude of R wave in aVL lead; SBP, systolic blood pressure.
Diagnostic value of ECG indexes for LVH
In the whole cohort, we observed area under ROC curves of 0.729 [0.680-0.778] for RaVL (P < 0.001, specificity 98.3%, sensitivity 19.6%, optimal cut-off 1.1 mV, 75.8% correctly classified), 0.608 [0.548-0.668] for Sokolow-Lyon index (P < 0.001, 98.6% specificity, 11.3% sensitivity, optimal cutoff 3.7 mV, 73.4% correctly classified), 0.795 [0.752-0.839] for Cornell voltage without Gender correction (p<0.001, specificity 84.6%, sensitivity 60.6%, optimal cut-off 1.9 mV, 77.6% correctly classified) and 0.803 [0.761-0.846] for Cornell product (P < 0.001, 86.0% specificity, 58.5% sensitivity, optimal cut-off 1,824 mm.ms, 78.1% correctly classified). The difference of area under ROC curves in comparison with RaVL were P < 0.001 for Sokolow-Lyon index, P = 0.010 for Cornell voltage and P = 0.003 for Cornell product.
The characteristics of the ROC curves of patients without MI are summarized in Table 2 . Overall, RaVL had a better diagnostic value than Sokolow-Lyon index ( Figure 1 ). RaVL had an area under the ROC curve similar to Cornell voltage and Cornell product for women (P = 0.947, P = 0.899, respectively), Caucasians (P = 0.508, P = 0.271, respectively), obese (P = 0.381, P = 0.400, respectively), patients with right bundle branch block (P = 0.262, P = 0.828, respectively) or with left deviation axis beyond −30° (P = 0.616, P = 0.420, respectively; Figure 2 ). On the other hand, Cornell voltage and Cornell product had a significant better diagnostic value for men (P = 0.027, P = 0.003, respectively), Africans (P = 0.024, P = 0.062, respectively, and a trend for normotensive patients (P = 0.109, P = 0.131, respectively) and left bundle branch block (P = 0.141, P = 0.084, respectively) ( Table 2) . Independently of subgroups, the optimal cut-off value of RaVL to detect LVH was around 1.0 mV with specificity beyond 90% and sensitivity around 40%. The picture was rather different for other LVH ECG indexes which demonstrated a large range of optimal cut-off values.
In the subgroup of patients with MI, ECG indexes demonstrated always good specificity ranging from 79.1% to 97.7% but a lower sensitivity (Supplementary Table S3 ). The optimal threshold to detect LVH for RaVL was 1.1 mV. Cornell voltage and Cornell product were overall the best indexes to diagnose LVH in these subgroups. However, we noted that Sokolow-Lyon index was of particular interest to detect LVH in patients with inferior MI with an optimal threshold of 2.3 mV.
Respective role of each ECG LVH leads
The multivariable analyses are illustrated in Table 3 . RaVL and SV1 were independently correlated with LVMI in patients with or without MI. SV3, RV5, and RV6 were independently correlated with LVMI only in patients without MI. SV3 and QRS duration were independently associated with LVEDVI in patients without MI. Globally, these results show that RaVL, SV1, RV5, and RV6 were correlated with LVMI but not with LVEDVI, contrarily to QRS duration and SV3, which were significantly associated with LVEDVI.
Multivariable logistic regression analyses used to determine LVH and LV enlargement with ECG leads are illustrated in Table 4 . In the subgroup of patients without MI, RaVL, and SV3 were the only independent predictors of LVH while both QRS duration and SV3 were predictors of LV enlargement. In patients with MI, SV1 was a predictor of LVH in addition to RaVL and SV3. SV3 was the sole predictor of LV enlargement. Taken as a whole, RaVL and SV3 are amongst the best predictors of LVH while SV3 is the best predictor of LV enlargement whatever the conditions. Figure 3 , we proposed a 2-step approach using as the first step RaVL (2 thresholds based on our ROC curves, the first one <0.5 mV for a good sensitivity and the second one >1.0 mV for a good specificity) and only as the second step, more sophisticated ECG indexes. This diagnostic strategy allows classifying correctly up to 85.0% patients. In Supplementary Figure S1 , we proposed a two steps approach using in first line RaVL (same thresholds as mentioned earlier) and in second line SV3 with a specific gender cut-off for patients without MI. This diagnostic strategy allows a better classification, which increases to 85.0% of patients correctly classified (255/300).
In the subgroup of patients with MI the diagnostic value of each criteria decreased significantly. RaVL classified correctly 68.5% of patients (>1.0 mV), Sokolow index 65.4% (>3.5 mV), Cornell voltage without gender correction 68.0% (>2.8 mV), Cornell voltage with 6 mm correction 68.5% (>2.8 mV), Cornell voltage with 8 mm correction 68.5% (>2.8 mV), Cornell product without gender correction 68.5% (>2,440 mm.ms), Cornell product with 6 mm correction 69.0% (>2,440 mm.ms) and Cornell product with 8 mm correction 69.0% (>2,440 mm.ms). Using the same diagnostic method described earlier in Figure 3 , the number of patients correctly classified range from 68.1% to 69.7% (Supplementary Figure S2) . Using the same diagnostic method described earlier in Supplementary Figure S1 , the number of patients with previous MI correctly classified did not drastically change compare to other LVH ECG indexes (69.2%, 139/201, data not shown).
DISCUSSION
The present study tested the performance of RaVL to detect LVH in a large cohort including different ethnic groups and various cardiac conditions in comparison to the gold standard CMR. We demonstrated that RaVL can be used in the first line in most cases to detect LVH and possibly completed by adding SV3 (composite criteria) since this later is independently related to LV enlargement and thus, witnesses a particular sort of LV remodeling. RaVL and SV3 appeared as the 2 major players in terms of prediction of cardiac remodeling with some differences. While RaVL is only a marker of LVH, SV3 is a marker of LV enlargement and consequently also of LVH. In most subgroups of our study, RaVL had a performance close to that of complex criteria and thus likely accounts for most of their predictive value (with the exception of the Sokolow-index). Its optimal threshold was consistently near 1.0 mV, while Cornell voltage criterion demonstrated important variations ranging from 1.9 to 2.9 mV. This last point is in accordance with previous studies which proposed a gender correction for women (addition from 0.4 to 0.8 mV) for SV3-derived criteria. 2, 3 Our results demonstrated that RaVL had a similar area under the ROC curve than Cornell voltage and Cornell product for women. It seems acceptable to screen ECG LVH in women only with RaVL and to keep more complex ECG criteria for men. On the other hand the kind of LV remodeling likely influences the performance of RaVL as compared to composite criteria. In hypertension, which implies mainly wall thickening and not ventricle enlargement, RaVL is doing very well. This is in line with studies from our group showing that RaVL has a very good diagnostic and prognostic value in this setting. 7, 9 Several studies which have previously tested RaVL in comparison with TTE reported most of the time a lower cut-off value of 0.6 mV. [4] [5] [6] This cut-off was also a good predictor of cardiovascular events and of mortality. 4 ,5,7 A major limit of ECG indexes is their poor sensitivity in comparison with TTE; they were considered of limited value in ruling out LVH in hypertensive patients. 13, 14 Our results showed that RaVL has a poor performance on average in the whole cohort; the value of RaVL was probably weakened by the inclusion of some subgroups, such as Africans or patients with a history of MI, in which RaVL exhibited a particularly low sensitivity (19.6%) to detect LVH. However, when considering only Caucasians without MI the sensitivity of RaVL rises to an acceptable level (around 40%) for an index of ECG-LVH. The present study also showed that a RaVL amplitude <0.5 mV had a very good specificity in excluding LVH, a condition associated with a better survival.
Moreover, TTE can overestimate LVMI in comparison to CMR, which is a second key point to explain the difference between our results and those mentioned above in terms of diagnostic threshold. 15 From our study, a 1.1 mV cut-off for RaVL can also be used to detect LVH in normotensive subjects. This result is in accordance with a previous study, which demonstrated a good correlation between RaVL and LVH in young subjects with hypertrophic cardiomyopathy. 16 SV3-derived indices are doing much better when remodeling implies enlargement: i.e., in the presence of LBB or ischemic cardiomyopathy. Little is known about the consequence of MI on ECG accuracy to detect LVH. One recent study addressed this question in 105 patients with a history of MI who had an assessment of LVMI by TTE. Sokolow-Lyon index, RaVL, Cornell voltage, and Cornell product were all associated with a good specificity (>90%) but a very low sensitivity (<15%). 17 Our results were similar, this time in comparison with CMR, and the optimal threshold for RaVL was still 1.1 mV. Of note, LVH status is not so important in the context of previous MI since this condition implies an aggressive treatment usually based on angiotensin converting enzyme inhibitors or beta-blockers to control strictly BP. In obese patients, diagnosing LVH is challenging. Several studies demonstrated that obesity is associated with an increased LVM using TTE but an increased QRS voltage in precordial lead. [18] [19] [20] [21] [22] A likely explanation is the adipose tissue that increases the distance between the heart and the chest-wall electrodes. Consistently, the Sokolow-Lyon index was shown to underestimate LVH in obese patients. 18, [20] [21] [22] Once again, in our study, RaVL had a good performance to detect LVH in the subset of obese patients, with an optimal threshold close to that observed in the whole cohort (0.9 mV).
As regards to conduction disorders, RBBB reduces the amplitude of the S wave in the right precordial leads and tends to reduce the sensitivity of ECG criteria for LVH. Several criteria have been proposed to be used specifically in the case of RBBB, including SV1 greater than 2 mm (0.2 mV), RV5 or RV6 greater than 15 mm (1.5 mV), and QRS axis to the left of −30°, with S III + largest R/S in a precordial lead greater than 30 mm (3.0 mV). These criteria were reported to have sensitivities of 46-68% and specificities of 57-71%. [23] [24] [25] [26] In our hands, RaVL >1.0 mV was associated with a specificity of 100% and a sensitivity of 54.6% with a same performance than the Cornell product. This result supports the use of RaVL as a first line criterion also in the setting of RBBB. Regarding the recommendations for the standardization and the interpretation of ECG, diagnosis of LVH should not be attempted when there is a LBBB. 27 Overall, our data confirmed a poor correlation between LVH and ECG indexes in presence of LBBB. However, in the small subgroup of patients without MI, only ECG indexes including SV3 seem to have a fair diagnostic value using higher threshold than those usually described. Our results are well in-line with a previous study focusing on patients with LBBB. 28 One can suppose that this association was observed because of the good correlation of SV3 with LVMI and LVEDVI. Nevertheless, this result must be confirmed in a larger cohort with LBBB. In left anterior fascicular block, criteria that include the depth of the S wave in left precordial leads improve detection of LVH. [29] [30] [31] The recommendations consider that RaVL is not a reliable criterion in this situation because QRS vector shifts in a posterior and superior direction, resulting in larger R waves in aVL lead. 27 This exclusion is still a matter of debate, since a recent study based on TTE demonstrated that RaVL-based criteria had similar diagnostic accuracy than those without RaVLbased criteria in the presence of left anterior fascicular block. 32 Our results strengthen this later study; indeed with an optimal cut-off of 1.0 mV RaVL was able to detect LVH with a specificity of 88.2% and a sensitivity of 54.2%. Practically, in patients without MI, we demonstrated that complex ECG indexes (Cornell voltage and product with or without gender correction) increased marginally the classification of patients in comparison with the simple 1.0 mV RaVL threshold (all values were between 80.3% and 82.4%). We proposed a 2-step strategy which is simple and raised the number of good classification up to 85.0%: (i) only consider RaVL if <0.5 mV (no LVH) or >1.0 mV (LVH) (ii) consider more complex ECG LVH indexes (Sokolow-Lyon, Cornell voltage criterion, Cornell product) if RaVL between 0.5 and 1.0 mV. This strategy has probably a rather similar performance than TTE to detect LVH. Indeed, specificity and sensibility of TTE are near 90% and a lack of LVMI measurement for technical reasons occurs in around 10% of patients. 15, [33] [34] [35] 
Limits
A theoretical limitation of the present study is that MRI and 12-lead ECG were not performed simultaneously. However, the median period between MRI and ECG was only 5 days which makes LVMI fluctuations very unlikely. The extrapolation of the present results to other ethnic groups cannot be readily supported because our population was mainly composed of Caucasians and Africans. In the latter ethnic group, RaVL failed to demonstrate a good diagnostic performance to detect LVH and ECG SV3-based criteria seems still useful. We cannot address the performance in Hispanic and Asian populations. Moreover, our cohort was mainly composed of middle-aged patients and whether these results apply to patients younger than 35 years, remains uncertain. While CMR is currently the gold standard to assess LVMI, cut-off values have been only established in normal populations and contrary to those obtained by TTE, the value of these thresholds was not assessed in terms of cardiovascular events prediction.
Our study validates for the first time in a large cohort an optimal cut-off value of RaVL to detect LVH using MRI as the gold standard. We demonstrated, in patients without MI, that an optimal cut-off of RaVL of 1.0 mV was able to classify correctly more than 80% of patients. We thus confirmed the good performance of this simple ECG index, which can be used largely in Caucasians as a first-line tool to detect LVH. We provide some new insight in terms of anatomical correlates with SV3 that may help understanding in which setting complex ECG indices are required. Based on these findings, an algorithm is proposed.
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